文献速递主动脉疾病

复杂主动脉弓病变的腔内与杂交手术中期结局

Mid-term Outcomes of Endovascular and Hybrid Procedures to Treat Complex Aortic Arch Pathologies.
PubMed 文献 · J Endovasc Ther · 2022-04-25

单中心回顾性分析59例复杂主动脉弓病变患者,45例行分支或开窗腔内手术、14例行杂交手术。杂交组费用更低但手术时间更长,解剖变异比例更高(28.6% vs 2.2%,p=0.011),上肢麻木更多(28.57% vs 0%,p=0.002);两组分支通畅率、内漏等无显著差异。

要点

  • 杂交组费用低于腔内组,手术时间长于腔内组(p<0.05)。
  • 杂交组解剖变异比例28.6%显著高于腔内组2.2%(p=0.011)。
  • 杂交组上肢麻木28.57%高于腔内组0%(p=0.002)。

核心结论

  • 杂交手术费用更低,更适合治疗主动脉弓解剖变异。
  • 腔内治疗仍受解剖条件限制。

研究设计与样本

  • 单中心回顾性分析2018年3月至2020年4月59例复杂主动脉弓病变患者,45例行分支或开窗腔内手术,14例行杂交手术。
  • 主要研究指标为随访期间分支通畅率和内漏率,次要指标包括手术成功率、手术时间、住院费用、并发症发生率、免于再干预率、死亡率等。

主要发现

  • 所有组手术成功率均为100%。
  • 杂交组住院费用低于腔内组(p<0.05),手术时间长于腔内组(p<0.05)。
  • 杂交组解剖变异发生率为28.6%,显著高于腔内组2.2%(p=0.011)。
  • 两组在术中出血量、呼吸机使用时长和重症监护室治疗时间方面无显著差异(p>0.05)。
  • 随访12至34个月,杂交组4例出现上肢麻木(28.57%),高于腔内组0%(p=0.002)。

关键数值与推荐

  • 两组内漏、逆行性主动脉夹层、靶病变、二次手术、分支通畅率、截瘫、脑卒中、肾功能衰竭等并发症发生率无显著差异(p>0.05)。
  • 腔内组死亡率为6.67%(3/45)。
  • 杂交组1年累积生存率为100%,腔内组为93.3%。
  • 两组真腔增加量用于血管重塑无统计学差异(p>0.05)。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the mid-term outcomes of endovascular and hybrid procedures in treating aortic arch pathologies with an unfavorable proximal landing zone, and analyze the different indications of the 2 methods. METHODS: We collected the clinical data from 59 patients with complex aortic arch pathologies who underwent endovascular or hybrid surgery from March 2018 to April 2020 at a single center. Among the patients, 45 were treated by branched or fenestrated surgery and 14 by hybrid surgery. The clinical data of preoperative, perioperative, and postoperative results were retrospectively analyzed and compared. The main study indexes were the branch patency rate and endoleakage rate during the follow-up period. The secondary study indexes included the operation success rate, operative time, hospital expenses, complication incidence, freedom from reintervention rate, mortality, etc. RESULTS: The operation success rate of all the groups was 100%. The hospital expenses of the hybrid group were lower than those of the endovascular group (p<0.05). The operative time of the hybrid group was longer than that of the endovascular group (p<0.05). The incidence of anatomic variants in the hybrid group was 28.6%, which was significantly higher than that in the endovascular group (2.2%, p=0.011). However, there were no significant differences in operative bleeding, ventilator use duration, and treatment time in intensive care units between the 2 groups (p>0.05). Follow-up was conducted for a period of 12 to 34 months. Four patients of the hybrid group experienced numbness of the upper limb (28.57%); the proportion was higher than the endovascular group (0%, p=0.002). There were no significant differences in the occurrence of endoleaks, retrograde aortic dissection, target lesion, secondary operation, branch patency rate, paraplegia, cerebral apoplexy, renal failure, or other complications in either group (p>0.05). The mortality of the endovascular group was 6.67% (3/45). Overall cumulative survival at 1 year was 100% in the hybrid group and 93.3% in the endovascular group. There was no statistical difference in the increase of the true lumen between the 2 groups for vascular remodeling (p>0.05). CONCLUSION: The hybrid surgery costs less and proves more suitable for treating variants of the aortic arch. The endovascular treatment still has limitations due to anatomical conditions.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Li P, Bi J, Niu F, et al. Mid-term Outcomes of Endovascular and Hybrid Procedures to Treat Complex Aortic Arch Pathologies. J Endovasc Ther. 2022. PMID: 35466783. doi:10.1177/15266028221091891

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。